Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.625 GBX | 0.00% | -3.85% | -26.47% |
Apr. 25 | N4 Pharma strikes partnership deal for intracellular delivery | AN |
Apr. 23 | N4 Pharma loss widens but "great optimism" remains | AN |
Quotes 5-day view
Delayed Quote London S.E.2024-06-03 | 2024-06-04 | 2024-06-05 | 2024-06-06 | |
---|---|---|---|---|
Last | 0.625 p | 0.625 p | 0.625 p | 0.625 p |
Volume | 1 121 978 | 374 192 | 414 346 | 27 902 |
Change | 0.00% | 0.00% | 0.00% | 0.00% |
Opening | 0.63 | 0.63 | 0.63 | 0.63 |
High | 0.65 | 0.65 | 0.63 | 0.65 |
Low | 0.60 | 0.60 | 0.60 | 0.65 |
Performance
1 week | -3.85% | ||
1 month | -21.88% | ||
3 months | -19.35% | ||
6 months | -16.67% | ||
Current year | -26.47% | ||
1 year | -63.24% | ||
3 years | -93.56% | ||
5 years | -78.81% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
0.00% | -3.85% | -26.47% | -63.24% | 2.15M | ||
+0.66% | +2.73% | +43.64% | +88.97% | 754B | ||
+3.96% | +6.15% | +39.42% | +72.94% | 630B | ||
+0.31% | +0.78% | -6.58% | -7.43% | 352B | ||
+0.83% | +4.81% | +19.72% | +18.64% | 331B | ||
+1.89% | +7.84% | +8.78% | +24.47% | 298B | ||
+0.52% | +4.12% | +11.92% | +4.94% | 217B | ||
+0.85% | +4.29% | -2.62% | -18.50% | 216B | ||
-2.54% | +2.13% | +0.03% | -24.94% | 163B | ||
-0.55% | +1.56% | +6.13% | +38.18% | 164B | ||
+0.35% | +2.75% | +1.39% | -5.56% | 124B | ||
-0.64% | -5.20% | +13.09% | +17.87% | 85.51B | ||
-0.87% | +1.57% | -20.33% | -37.57% | 82.87B | ||
-0.06% | -0.37% | -21.19% | -16.22% | 79.55B | ||
+0.36% | +3.84% | +49.59% | +21.40% | 70.73B | ||
-.--% | +1.73% | - | - | 63.66B | ||
Average | +0.37% | +2.39% | +7.77% | +7.60% | ||
Weighted average by Cap. | +0.97% | +3.65% | +19.34% | +33.94% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Last transactions
Date | Price | Volume | Daily volume |
---|
Monthly variations
Annual change
2024 | -26.47% | ||
2023 | -54.05% | ||
2022 | -58.43% | ||
2021 | -46.71% | ||
2020 | +203.64% | ||
2019 | -70.59% | ||
2018 | -7.65% | ||
2017 | +58.82% |
- Stock Market
- Equities
- ONZ Stock
- Quotes N4 Pharma Plc